Shawn Li, principal scientist at Merck & Co., known as MSD outside the Unites States and Canada, talked about the importance ...

Natalie from “The Nerve of My Multiple Sclerosis,” highlights challenges faced by the Black MS community, advocates for greater visibility and support within the MS community. In this blog she shares ...

Glaucoma Therapeutics MarketThe global glaucoma therapeutics market is projected to be valued at approximately USD 6.9 ...

from capturing and nurturing leads at the booth to providing insightful post-event analytics ... SCC tests in guiding risk-aligned treatment... 19 oct 2024 Gilead and Merck Announce Phase 2 Data ...

Hyundai Mobis (KRX: 012330), is accelerating its European market strategy by participating in the Paris Motor Show, Europe's largest automotive exhibition. After achieving a ...

Sponsors and industry leaders such as Merck, Novartis ... At CancerCon 2024, H2Ocean’s booth was a hub of activity, with cancer survivors, healthcare professionals, and caregivers eager to ...

Merck (MRK) reachead $106.64 at the closing of the latest trading day, reflecting a +0.28% change compared to its last close. Visa, Netflix, Merck and Hovnanian are included in this Analyst Blog ...

It is hard to get excited after looking at Merck's (NYSE:MRK) recent performance, when its stock has declined 13% over the past three months. However, stock prices are usually driven by a company ...

Merck & Co. has picked up options on two Evaxion Biotech vaccine candidates, paying $3.2 million and dangling more than $1 billion in milestones for the chance to pick up preclinical prospects ...

Merck's Keytruda could face competition from a newer medicine. The company's crown jewel will also lose patent exclusivity in a few years. Merck should have the means to get around these headwinds ...